Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity

Although B cell response is frequently found in cancer, there is little evidence that it alters tumor development or progression. The process through which tumor-associated antigens trigger humoral response is not well delineated. We investigate the repertoire of antigens associated with humoral imm...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 10; no. 1; pp. 254 - 13
Main Authors Capello, Michela, Vykoukal, Jody V., Katayama, Hiroyuki, Bantis, Leonidas E., Wang, Hong, Kundnani, Deepali L., Aguilar-Bonavides, Clemente, Aguilar, Mitzi, Tripathi, Satyendra C., Dhillon, Dilsher S., Momin, Amin A., Peters, Haley, Katz, Matthew H., Alvarez, Hector, Bernard, Vincent, Ferri-Borgogno, Sammy, Brand, Randall, Adler, Douglas G., Firpo, Matthew A., Mulvihill, Sean J., Molldrem, Jeffrey J., Feng, Ziding, Taguchi, Ayumu, Maitra, Anirban, Hanash, Samir M.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 16.01.2019
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text
ISSN2041-1723
2041-1723
DOI10.1038/s41467-018-08109-6

Cover

More Information
Summary:Although B cell response is frequently found in cancer, there is little evidence that it alters tumor development or progression. The process through which tumor-associated antigens trigger humoral response is not well delineated. We investigate the repertoire of antigens associated with humoral immune response in pancreatic ductal adenocarcinoma (PDAC) using in-depth proteomic profiling of immunoglobulin-bound proteins from PDAC patient plasmas and identify tumor antigens that induce antibody response together with exosome hallmark proteins. Additional profiling of PDAC cell-derived exosomes reveals significant overlap in their protein content with immunoglobulin-bound proteins in PDAC plasmas, and significant autoantibody reactivity is observed between PDAC cell-derived exosomes and patient plasmas compared to healthy controls. Importantly, PDAC-derived exosomes induce a dose-dependent inhibition of PDAC serum-mediated complement-dependent cytotoxicity towards cancer cells. In summary, we provide evidence that exosomes display a large repertoire of tumor antigens that induce autoantibodies and exert a decoy function against complement-mediated cytotoxicity. The humoral immune response role in cancer is unclear. Here the authors perform an in-depth proteomic profiling of immunoglobulin-bound proteins in plasma from pancreatic ductal adenocarcinoma patients and find cancer-cell specific antibodies neutralized by binding to cancer-cell derived exosomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-018-08109-6